Reported valuation; nothing comparable since.
- ·13 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
TRexBio funding history
No funding rounds for TRexBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
TRexBio valuation
TRexBio is valued at approximately $274 million as of Oct 2026. The figure is set by institutional fund marks.
Institutional holders and vehicles
4 SEC-registered funds reported 13 fair-value marks on TRexBio between Apr 2025 and Oct 2025, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How TRexBio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For TRexBio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about TRexBio
- What is TRexBio worth?
- TRexBio is valued at $274.0M as of Oct 2026. Reported valuation; nothing comparable since.
- How much has TRexBio raised?
- TRexBio has raised $222.1M in total funding across its recorded rounds.